文献
J-GLOBAL ID:202002284415057157
整理番号:20A0582234
進行性ALK再配列非小細胞肺癌患者におけるセリチニブ+ニボルマブ: オープンラベル,多施設,第1相試験の結果【JST・京大機械翻訳】
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
著者 (18件):
Felip Enriqueta
(Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona, Spain)
,
de Braud Filippo G.
(University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Maur Michela
(AOU Policlinico of Modena, University of Modena and Reggio Emilia, Modena, Italy)
,
Loong Herbert H.
(The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China)
,
Shaw Alice Tsang
(Massachusetts General Hospital, Boston, Massachusetts)
,
Vansteenkiste Johan F.
(University Hospital KU Leuven, Leuven, Belgium)
,
John Thomas
(Austin Health, Melbourne, Australia)
,
Liu Geoffrey
(Princess Margaret Cancer Centre, Toronto, Ontario, Canada)
,
Lolkema Martijn P.
(Erasmus MC Cancer Institute, Rotterdam, The Netherlands)
,
Selvaggi Giovanni
(Bristol-Myers Squibb, Princeton, New Jersey)
,
Giannone Vanessa
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Cazorla Pilar
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Baum Jason
(Novartis Institutes for Biomedical Research, Cambridge, Massachusetts)
,
Balbin O. Alejandro
(Novartis Institutes for Biomedical Research, Cambridge, Massachusetts)
,
Wang Luojun (Victor)
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Lau Yvonne Y.
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Scott Jeffrey W.
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Tan Daniel Shao-Weng
(National Cancer Centre Singapore, Singapore)
資料名:
Journal of Thoracic Oncology
(Journal of Thoracic Oncology)
巻:
15
号:
3
ページ:
392-403
発行年:
2020年
JST資料番号:
W3145A
ISSN:
1556-0864
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)